Hikma Pharmaceuticals PLC (HKMPY) Shareholder/Analyst Call Transcript [Seeking Alpha]
HIKMA PHARMS PLC S/ADR (HKMPY)
NASDAQ:AMEX Investor Relations:
hikma.com/en/investors.html
Company Research
Source: Seeking Alpha
Riad Mishlawi - Interim Head of Injectables Business, CEO & Director Khalid Nabilsi - Chief Financial Officer Conference Call Participants Zain Ebrahim - JPMorgan Chase & Co, Research Division Charlie Haywood - BofA Securities, Research Division Christian Glennie - Stifel, Nicolaus & Company, Incorporated, Research Division Victor Floch - BNP Paribas, Research Division Beatrice Fairbairn - Joh. Berenberg, Gossler & Co. KG, Research Division Kane Slutzkin - Deutsche Bank AG, Research Division James Vane-Tempest - Jefferies LLC, Research Division Sebastien Jantet - Panmure Liberum Limited, Research Division Miles Dixon - Peel Hunt LLP, Research Division Presentation Operator Good day, ladies and gentlemen, and welcome to Hikma November 2025 Trading Update. [Operator Instructions] I will now hand over to Investor Relations for opening remarks. Please go ahead. Unknown Executive Thank you. Before we start, we'd like to remind you that any forward-looki
Show less
Read more
Impact Snapshot
Event Time:
HKMPY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HKMPY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HKMPY alerts
High impacting HIKMA PHARMS PLC S/ADR news events
Weekly update
A roundup of the hottest topics
HKMPY
News
- How Recent Developments Are Shaping the Hikma Pharmaceuticals Story and Its Valuation [Yahoo! Finance]Yahoo! Finance
- Ritedose Now Offers the Largest Nebulized Drug Portfolio in the U.S.: FDA Approves the Company to Manufacture Generic Tobramycin Inhalation Solution [Yahoo! Finance]Yahoo! Finance
- In Texas, new details about its execution drug underscore a closely guarded secret [MSNBC.com]MSNBC.com